Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nuran Türkçapar is active.

Publication


Featured researches published by Nuran Türkçapar.


Clinical Rheumatology | 2006

A multicenter study of patients with adult-onset Still’s disease compared with systemic juvenile idiopathic arthritis

Salih Pay; Nuran Türkçapar; Mukaddes Kalyoncu; İsmail Şimşek; Esin Beyan; I. Ertenli; M. Akif Öztürk; Nurşen Düzgün; Hakan Erdem; Zeynep Ozbalkan; Sedat Kiraz; Gülay Kinikli; Nesrin Besbas; Ayhan Dinc; Aşkın Ateş; Ümit Ölmez; Meral Calguneri; Olcay Tiryaki Aydintug; Aysin Bakkaloglu; Mustafa Turan; Murat Turgay; Yasar Karaaslan; R. Topaloglu; Murat Duman; Seza Ozen

Adult-onset Still’s disease (AOSD) has often been regarded as the adult spectrum of systemic juvenile idiopathic arthritis (sJIA). The present study aims to compare the clinical and laboratory features, the disease course and the response to treatment in patients having AOSD with those having sJIA. Retrospective review of all available data that were filled out by adult and paediatric rheumatologists from six centers using a standard data extraction form was performed. A total of 95 patients with AOSD and 25 patients with sJIA were recruited for the study. The frequency of fever, rash, myalgia, weight loss and sore throat was higher in patients with AOSD. The pattern of joint involvement differed slightly. Laboratory findings were similar in both groups, except that liver dysfunction and neutrophilia were more common among adults. A multiphasic pattern dominated the childhood cases, whereas the most frequent course was a chronic one in adults. Corticosteroids and methotrexate were the most commonly employed therapy; however, chloroquine was another popular therapy in the adult group. We showed a difference in the rate of clinical and laboratory features between patients with AOSD and those with sJIA. AOSD and sJIA may still be the same disease, and children may simply be reacting differently as the result of the first encounter of the putative antigens with the immune system.


Nephron | 2002

PREVALENCE OF CRYPTOSPORIDIUM INFECTION IN HEMODIALYSIS PATIENTS

Nuran Türkçapar; Sim Kutlay; Gokhan Nergizoglu; Teslime Atli; Neval Duman

The prevalence of Cryptosporidium infection in patients who are on chronic hemodialysis due to end-stage renal failure is investigated and compared with the incidence in the healthy population. Stool specimens of 74 adult hemodialysis patients treated on an outpatient basis and 50 healthy individuals are examined for Cryptosporidium oocysts by using the modified acid-fast method. While 20.27% (15/74) of patients in the dialysis group had Cryptosporidium oocysts in their stools, none (0/50) of the controls had such an infection (p < 0.001). Ten of 15 patients who had Cryptosporidium oocysts in their stool specimens were asymptomatic and the remaining 5 had diarrhea. Four of these 5 diarrheic patients had Cryptosporidium oocysts in their stools and 1 had both Cryptosporidium oocysts and Giardia trophozoites. Since hemodialysis patients with chronic renal failure are candidates for renal transplantation, general preventive measures against infection must be taken and these patients must be screened for their carrier state before transplantation.


Rheumatology International | 2007

Serum pro-matrix metalloproteinase-3 as an indicator of disease activity and severity in rheumatoid arthritis: comparison with traditional markers

Aşkın Ateş; Nuran Türkçapar; Ümit Ölmez; Olcay Tiryaki; Nurşen Düzgün; Emre Uğuz; Murat Duman

Matrix metalloproteinase-3 (MMP-3) production increases in rheumatoid arthritis (RA) and has been proposed as a marker of disease activity and joint damage. The aim of this cross-sectional study is to examine the usefulness of serum proMMP-3 as an indicator of disease activity and severity in comparison with erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). Serum proMMP-3 was measured by a quantitative ELISA in 85 RA patients and 70 healthy subjects. Clinical and laboratory measures of disease activity and severity were obtained. Radiological joint damage was assessed by the method of Larsen. Serum proMMP-3 was significantly higher in RA patients than that in the healthy subjects. The active RA patients had significantly higher serum proMMP-3 than the inactive patients. Serum proMMP-3 was significantly correlated with some parameters of disease activity including swollen joints count, proximal interphalangeal joint score, morning stiffness, and Health Assessment Questionnaire; however, ESR and serum CRP were better correlated with all indicators of the disease activity than proMMP-3. The analysis of receiver operating characteristic supported that ESR and CRP had higher performance for reflection of activity compared to proMMP-3. There were no significant associations among Larsen score and proMMP-3, ESR, and CRP. Our results suggest that the cross-sectional measurement of serum proMMP-3 could not give additional information about RA disease activity compared to ESR and CRP, and could not give any information about joint damage.


Rheumatology International | 2006

The importance of alpha-fodrin antibodies in the diagnosis of Sjögren’s syndrome

Nuran Türkçapar; Ümit Ölmez; Hüseyin Tutkak; Murat Duman

Objective: We wanted to determine the prevalence of IgA and IgG antibodies against alpha-fodrin in the patients with primary and secondary Sjögren’s syndrome (SS) and also to compare with anti-Ro and anti-La antibodies in the diagnosis of SS. Methods: We tested the prevalence of anti-alpha-fodrin IgA, IgG, anti-Ro, anti-La antibodies, anti-nuclear antibodies (ANA) and rheumatoid factor (RF) in naive patients with primary (n=20) and secondary SS (n=20) (Rheumatoid Arthritis [RA]+SS, n=10; Systemic Lupus Erythematosus [SLE]+SS, n=10), RA (n=10), SLE (n=10) and in healthy controls (n=20). Salivary gland biopsies were performed in the patients with primary and secondary SS. Results: In primary SS, anti-alpha-fodrin IgA, IgG, anti-Ro and anti-La antibodies were detected as 20, 10, 55 and 20% respectively. In RA+SS, anti-alpha-fodrin IgA was detected to be 10% and IgG was negative; however, anti-Ro antibodies and anti-La antibodies were found to be 40% and 20% respectively. In SLE+SS, anti-alpha-fodrin IgA was found to be 20% and IgG was found to be 10%, but anti-Ro and anti-La antibodies were found to be 90% and 20% respectively. Alpha-fodrin antibodies were not detected in RA, SLE and healthy controls. Conclusion: The detection of anti-alpha-fodrin antibodies by used ELISA does not give much contribution to the diagnosis of SS, and anti-Ro and anti-La are still useful serological markers in the diagnosis of SS.


Rheumatology International | 2006

The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease

Nuran Türkçapar; Murat Törüner; Irfan Soykan; Olcay Tiryaki Aydintug; Hülya Çetinkaya; Nurşen Düzgün; Ali Özden; Murat Duman


Archives of Gerontology and Geriatrics | 2004

Oxidative stress and antioxidant status in elderly diabetes mellitus and glucose intolerance patients.

Teslime Atli; Aslıhan Avcı; Sim Kutlay; Nuran Türkçapar; Murat Varli; Sevgi Aras; Ergun Ertug; Orhan Canbolat


Archives of Gerontology and Geriatrics | 2006

Late onset rheumatoid arthritis: Clinical and laboratory comparisons with younger onset patients

Nuran Türkçapar; Özgür Demir; Teslime Atli; Murat Kopuk; Murat Turgay; Gülay Kinikli; Murat Duman


The Journal of Rheumatology | 2005

Vasculitis and expression of vascular cell adhesion molecule-1, intercellular adhesion molecule-1, and E-selectin in salivary glands of patients with Sjögren's syndrome.

Nuran Türkçapar; Serpil Dizbay Sak; Mustafa Saatci; Murat Duman; Ümit Ölmez


Rheumatology International | 2007

The contribution of genotypes at the MICA gene triplet repeat polymorphisms and MEFV mutations to amyloidosis and course of the disease in the patients with familial Mediterranean fever

Nuran Türkçapar; Timur Tuncali; Sim Kutlay; Basak Yalcin Burhan; Gülay Kinikli; Sehsuvar Erturk; Murat Duman


Rheumatology International | 2005

Specific immunotherapy-induced Sjögren's syndrome.

Nuran Türkçapar; Gülay Kinikli; S. Dizbay Sak; Murat Duman

Collaboration


Dive into the Nuran Türkçapar's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Murat Duman

Dokuz Eylül University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge